Upstream Bio (UPB) Shares Outstanding (2023 - 2026)
Upstream Bio (UPB) recorded quarterly Shares Outstanding of $54.4 million in Q1 2026, little changed quarter-over-quarter from $54.2 million in Q4 2025, and up 1.45% on a YoY basis from $53.6 million in Q1 2025.
Upstream Bio (UPB) Shares Outstanding (2023 - 2026) Analysis & Trends
Upstream Bio's Shares Outstanding history runs 4 years deep, the most recent figure standing at $54.4 million for Q1 2026.
- In Q1 2026, Shares Outstanding rose 1.45% year-over-year to $54.4 million; the TTM figure through Mar 2026 stood at $54.4 million (up 1.45% YoY), while the FY2025 annual figure was $54.2 million, up 1.18% from the prior year.
- Shares Outstanding was $54.4 million for Q1 2026 at Upstream Bio, roughly flat from $54.2 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $54.4 million in Q1 2026 to a low of $3.0 million in Q3 2023.
- Historically, Shares Outstanding has averaged $30.8 million across 4 years, with a median of $53.6 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding soared 1691.27% in 2024, then gained 1.18% in 2025.
- A 4-year view of Shares Outstanding shows it stood at $3.0 million in 2023, then jumped by 1691.27% to $53.6 million in 2024, then grew by 1.18% to $54.2 million in 2025, then increased by 0.34% to $54.4 million in 2026.
- The last three Shares Outstanding figures came in at $54.4 million (Q1 2026), $54.2 million (Q4 2025), and $54.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn | 54.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Mar 31, 2026 | 54.42 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Dec 31, 2025 | 54.24 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Sep 30, 2025 | 54.00 Mn |